John C. Goodman
Freelance Contributor at Freelance
CEO & Founder of @GoodmanInst & author of Priceless: Curing the Healthcare Crisis (@independentinst). Known as the Father of Health Savings Accounts.
Articles
-
3 weeks ago |
forbes.com | John C. Goodman
Should the government allow HSAs to cover gym memberships? gettyHealth Savings Accounts (HSAs) are a popular and important way many people pay for medical expenses. They are also a great way to save—better, for example, than an IRA or a 401(k) plan. Because of various quirks in the law, HSAs are not available to a large number of people—including people on Medicaid or Medicare and most people who buy their own insurance in the (Obamacare) exchanges.
-
3 weeks ago |
forbes.com | John C. Goodman
The U.S. has fewer hospital beds per person than Europe does. gettyIn evaluating the success of Obamacare in general and Medicaid expansion in particular, reporters and commentators have tended to focus on only one measure: the increase in the number of people with health insurance. At the same time, in evaluating the health consequences of the House Republican reconciliation measure, almost all the focus has been on the number of people who will lose health insurance.
-
1 month ago |
forbes.com | John C. Goodman
In the previous two columns, we saw how a free health care market would arrive at prices for brand drugs. In this column I will briefly discuss what the federal government is now doing, why political decision-making faces perverse incentives, why private insurers also face perverse incentives and how we can move in the direction of free market reforms.
-
1 month ago |
forbes.com | John C. Goodman
In response to Donald Trump’s invitation to a national discussion on how much we should pay for drugs, I proposed in Part I to take the same approach economists take toward most public policies. That is, we begin by asking what would happen in a completely free market. Then, we ask whether government intervention of some sort would improve social welfare. In Part I, I surveyed the seller side of the market. Let’s now turn to the buyer side.
-
1 month ago |
forbes.com | John C. Goodman
President Trump thinks Americans pay too much for brand drugs. Under his proposal, the U.S. would pay the lowest price for American-made drugs sold to other developed countries. Right now, Americans pay about three times more than the average price paid in OECD countries. So even if we merely matched the average price other countries pay, that would be a substantial reduction. More than one critic has noted that if you limit drug company income, we will get fewer new drugs.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →X (formerly Twitter)
- Followers
- 2K
- Tweets
- 1K
- DMs Open
- No
Where DOGE And The Tax Bill Intersect - https://t.co/3Dq5kS4ZYu
RFK, Jr. May Be Right About Something - https://t.co/teeAuHjhAQ
The last election has provoked much soul searching and introspection on the left. Surprisingly, voters who were supposed to vote for left wing candidates voted for their opponents instead. Here is the problem. From Paul Krugman to Matt Yglesias, there is an unquestioned belief